Lunai Bioworks Inc. (LNAI)Healthcare | Biotechnology | Los Angeles, United States | NasdaqCM
0.35 USD
+0.04
(14.770%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.33 -0.02 (-0.019%) ⇩ (April 17, 2026, 7:34 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 1:03 a.m. EDT
LNAI is a high-risk specimen trading near bankruptcy territory (negative book value, massive debt vs. cash, severe operational losses). Despite recent news regarding a strategic transaction and Nasdaq listing hopes, the quantitative models predict a 11% drop in the next 45 days. The market has ignored the fundamental deterioration in favor of lottery-ticket call buying, but the odds are strongly stacked against sustaining any momentum. Avoid both for yield and capital preservation. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.586315 |
| AutoARIMA | 0.609539 |
| AutoETS | 0.614929 |
| MSTL | 0.624510 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 26.12 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.549 |
| Excess Kurtosis | -0.51 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 12,654,993 |
| Beta | 0.50 |
| Previous Name | Enochian Biosciences, Inc. |
| Website | https://www.lunaibioworks.com |
As of April 19, 2026, 1:03 a.m. EDT: Speculators are positioning for long-duration calls (OTM OI at $7.50 and $5.00 or beyond) while placing minimal protection (pigeonholing is low relative to calls). This indicates a speculative 'moon shot' bias focused on biotech milestones rather than price stability. However, the Jupyter-predicted adjusted direction is significantly negative (-11%), suggesting the options flow is overly optimistic compared to the statistical model's forecast of continued decline. The extremely low implied volatility and distinct lack of Put OI beyond deep ITM suggest a 'buy call, no hedge' strategy common in 'quote-worthy' NASDAQ micro-caps anticipating a binary event.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.91318405 |
| Address1 | 2,080 Century Park East |
| Address2 | Suite 906 |
| All Time High | 137.8 |
| All Time Low | 0.151 |
| Ask | 0.36 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 18,993,260 |
| Average Daily Volume3 Month | 19,250,255 |
| Average Volume | 19,250,255 |
| Average Volume10Days | 18,993,260 |
| Beta | 0.495 |
| Bid | 0.3471 |
| Bid Size | 1 |
| Book Value | -0.56 |
| City | Los Angeles |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.3489 |
| Current Ratio | 0.026 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.3628 |
| Day Low | 0.2999 |
| Display Name | Lunai Bioworks |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -12,458,986 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.859 |
| Enterprise Value | 10,701,120 |
| Eps Trailing Twelve Months | -7.56 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.44008 |
| Fifty Day Average Change | -0.09118 |
| Fifty Day Average Change Percent | -0.2071896 |
| Fifty Two Week Change Percent | -91.318405 |
| Fifty Two Week High | 5.5 |
| Fifty Two Week High Change | -5.1511 |
| Fifty Two Week High Change Percent | -0.9365637 |
| Fifty Two Week Low | 0.151 |
| Fifty Two Week Low Change | 0.1979 |
| Fifty Two Week Low Change Percent | 1.3105961 |
| Fifty Two Week Range | 0.151 - 5.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,518,013,800,000 |
| Float Shares | 14,705,912 |
| Free Cashflow | -8,343,209 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 29 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.31350002 |
| Held Percent Institutions | 0.0307 |
| Implied Shares Outstanding | 36,271,119 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,751,241,600 |
| Last Split Date | 1,759,190,400 |
| Last Split Factor | 1:10 |
| Long Business Summary | Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California. |
| Long Name | Lunai Bioworks Inc. |
| Market | us_market |
| Market Cap | 12,654,993 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_549849556 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-19 |
| Net Income To Common | -125,523,440 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 12,440,993 |
| Open | 0.3 |
| Operating Cashflow | -5,718,918 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 305 918 1980 |
| Post Market Change | -0.01909998 |
| Post Market Change Percent | -5.4743423 |
| Post Market Price | 0.3298 |
| Post Market Time | 1,776,468,867 |
| Prev Name | Enochian Biosciences, Inc. |
| Previous Close | 0.304 |
| Price Hint | 4 |
| Price To Book | -0.62303567 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.025 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0449 |
| Regular Market Change Percent | 14.7697 |
| Regular Market Day High | 0.3628 |
| Regular Market Day Low | 0.2999 |
| Regular Market Day Range | 0.2999 - 0.3628 |
| Regular Market Open | 0.3 |
| Regular Market Previous Close | 0.304 |
| Regular Market Price | 0.3489 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 2,721,345 |
| Return On Assets | -0.13322 |
| Return On Equity | -3.66435 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 36,271,119 |
| Shares Percent Shares Out | 0.0624 |
| Shares Short | 1,509,300 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 793,232 |
| Short Name | Lunai Bioworks Inc. |
| Short Percent Of Float | 0.0736 |
| Short Ratio | 0.03 |
| Source Interval | 15 |
| State | CA |
| Symbol | LNAI |
| Total Cash | 491,645 |
| Total Cash Per Share | 0.02 |
| Total Debt | 2,753,796 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -7.56 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.325805 |
| Two Hundred Day Average Change | -0.976905 |
| Two Hundred Day Average Change Percent | -0.7368392 |
| Type Disp | Equity |
| Volume | 2,721,345 |
| Website | https://www.lunaibioworks.com |
| Zip | 90,067 |